XML 52 R16.htm IDEA: XBRL DOCUMENT v3.19.3
SHAREHOLDERS' EQUITY (Note)
9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
SHAREHOLDERS' EQUITY SHAREHOLDERS' EQUITY 
Basic and diluted income per share was determined based on the following share data (in thousands):
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
 
2019
 
2018
 
2019
 
2018
Weighted average basic common shares
12,890

 
12,799

 
12,805

 
12,437

Effect of stock options
726

 
758

 
760

 
1,160

Effect of dilutive share awards
136

 
110

 
176

 
167

Effect of Convertible Senior Notes and warrants
880

 
183

 
888

 
535

Weighted average diluted common shares
14,632

 
13,850

 
14,629

 
14,299


For each of the three and nine months ended September 30, 2019, the weighted average shares that were anti-dilutive, and therefore excluded from the calculation of diluted income per share, included options to purchase 0.1 million shares of common stock. For the three months ended September 30, 2018, the weighted average shares that were anti-dilutive included options to purchase 0.5 million shares of common stock and 0.1 million restricted stock units. For the nine months ended September 30, 2018, the weighted average shares that were anti-dilutive included options to purchase 0.4 million shares of common stock.
The 0.625% Convertible Senior Notes due June 1, 2022 and the warrants issued by the Company in 2017 could be converted into the Company’s common stock, subject to certain contingencies. See Note 13—Debt for additional information.
Shares of the Company's common stock associated with the warrants were excluded from the calculation of diluted income per share for the three months ended September 30, 2018 as they were anti-dilutive since the strike price of the warrants was greater than the average market price of the Company's common stock during the period.
Common Stock Repurchases
In each of February 2018 and February 2019, the board of directors authorized and the Company announced the repurchase of up to $100.0 million and $150.0 million, respectively, of LendingTree's common stock. During the first nine months of 2019 and 2018, the Company purchased 18,580 and 205,310 shares, respectively, of its common stock for aggregate consideration of $4.3 million and $57.2 million, respectively. At September 30, 2019, approximately $180.9 million of the previous authorizations to repurchase common stock remain available.